[Drug-induced hepatitis. Local monitoring criteria].
D000777:Anesthetics / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D013956:Antithyroid Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000517:prevention & control; D004334:Drug Administration Schedule; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D004364:Pharmaceutical Preparations / Q000378:metabolism; D011619:Psychotropic Drugs / Q000009:adverse effects; D013256:Steroids / Q000009:adverse effects
D000777:Anesthetics; D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D013956:Antithyroid Agents; D000995:Antitubercular Agents; D007004:Hypoglycemic Agents; D004364:Pharmaceutical Preparations; D011619:Psychotropic Drugs; D013256:Steroids
Epatiti da farmaci. Criteri di monitoraggio nel territorio.